
### [MONDO:0005304](http://purl.obolibrary.org/obo/MONDO_0005304)
**Label:** biliary tract neoplasm (disease)

**Subclasses:** [MONDO:0002518](http://purl.obolibrary.org/obo/MONDO_0002518) (gallbladder papillary neoplasm), [MONDO:0000978](http://purl.obolibrary.org/obo/MONDO_0000978) (extrahepatic bile duct lipoma), [MONDO:0000972](http://purl.obolibrary.org/obo/MONDO_0000972) (gallbladder lipoma), [MONDO:0003444](http://purl.obolibrary.org/obo/MONDO_0003444) (intrahepatic bile duct adenoma), [MONDO:0000373](http://purl.obolibrary.org/obo/MONDO_0000373) (gall bladder carcinoma in situ), [MONDO:0003445](http://purl.obolibrary.org/obo/MONDO_0003445) (extrahepatic bile duct adenoma), [MONDO:0000374](http://purl.obolibrary.org/obo/MONDO_0000374) (bile duct carcinoma in situ), [MONDO:0006476](http://purl.obolibrary.org/obo/MONDO_0006476) (undifferentiated gallbladder carcinoma), [MONDO:0003364](http://purl.obolibrary.org/obo/MONDO_0003364) (gallbladder leiomyosarcoma), [MONDO:0003089](http://purl.obolibrary.org/obo/MONDO_0003089) (bile duct mucoepidermoid carcinoma), [MONDO:0002670](http://purl.obolibrary.org/obo/MONDO_0002670) (ampulla of vater adenocarcinoma), [MONDO:0004451](http://purl.obolibrary.org/obo/MONDO_0004451) (sarcomatous intrahepatic cholangiocarcinoma), [MONDO:0003286](http://purl.obolibrary.org/obo/MONDO_0003286) (extrahepatic bile duct leiomyoma), [MONDO:0004250](http://purl.obolibrary.org/obo/MONDO_0004250) (extrahepatic bile duct papillary adenoma), [MONDO:0021662](http://purl.obolibrary.org/obo/MONDO_0021662) (bile duct neoplasm), [MONDO:0004509](http://purl.obolibrary.org/obo/MONDO_0004509) (intrahepatic biliary papillomatosis), [MONDO:0003979](http://purl.obolibrary.org/obo/MONDO_0003979) (intrahepatic bile duct cystadenoma), [MONDO:0004148](http://purl.obolibrary.org/obo/MONDO_0004148) (gallbladder papillary carcinoma), [MONDO:0003455](http://purl.obolibrary.org/obo/MONDO_0003455) (bile duct papillary neoplasm), [MONDO:0004346](http://purl.obolibrary.org/obo/MONDO_0004346) (signet ring cell intrahepatic cholangiocarcinoma), [MONDO:0004149](http://purl.obolibrary.org/obo/MONDO_0004149) (gallbladder pleomorphic giant cell adenocarcinoma), [MONDO:0004465](http://purl.obolibrary.org/obo/MONDO_0004465) (periampullary adenocarcinoma), [MONDO:0006203](http://purl.obolibrary.org/obo/MONDO_0006203) (extrahepatic bile duct squamous cell carcinoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0003059](http://purl.obolibrary.org/obo/MONDO_0003059) (bile duct cancer), [MONDO:0004067](http://purl.obolibrary.org/obo/MONDO_0004067) (gallbladder mucinous adenocarcinoma), [MONDO:0006202](http://purl.obolibrary.org/obo/MONDO_0006202) (extrahepatic bile duct adenosquamous carcinoma), [MONDO:0003210](http://purl.obolibrary.org/obo/MONDO_0003210) (intrahepatic cholangiocarcinoma), [MONDO:0021385](http://purl.obolibrary.org/obo/MONDO_0021385) (tumor of extrahepatic bile duct), [MONDO:0004462](http://purl.obolibrary.org/obo/MONDO_0004462) (extrahepatic bile duct cystadenoma), [MONDO:0003490](http://purl.obolibrary.org/obo/MONDO_0003490) (ampulla of vater squamous cell carcinoma), [MONDO:0003090](http://purl.obolibrary.org/obo/MONDO_0003090) (extrahepatic bile duct carcinoma), [MONDO:0012439](http://purl.obolibrary.org/obo/MONDO_0012439) (Alagille syndrome due to a NOTCH2 point mutation), [MONDO:0016862](http://purl.obolibrary.org/obo/MONDO_0016862) (Alagille syndrome due to a JAG1 point mutation), [MONDO:0000919](http://purl.obolibrary.org/obo/MONDO_0000919) (ampulla of vater cancer), [MONDO:0002739](http://purl.obolibrary.org/obo/MONDO_0002739) (bile duct mucinous adenocarcinoma), [MONDO:0016861](http://purl.obolibrary.org/obo/MONDO_0016861) (Alagille syndrome due to 20p12 microdeletion), [MONDO:0003707](http://purl.obolibrary.org/obo/MONDO_0003707) (distal biliary tract carcinoma), [MONDO:0003708](http://purl.obolibrary.org/obo/MONDO_0003708) (extrahepatic bile duct small cell adenocarcinoma), [MONDO:0002857](http://purl.obolibrary.org/obo/MONDO_0002857) (gallbladder sarcoma), [MONDO:0002736](http://purl.obolibrary.org/obo/MONDO_0002736) (ampulla of vater mucinous adenocarcinoma), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0021299](http://purl.obolibrary.org/obo/MONDO_0021299) (carcinoma in situ of extrahepatic bile duct), [MONDO:0002856](http://purl.obolibrary.org/obo/MONDO_0002856) (gallbladder rhabdomyosarcoma), [MONDO:0003549](http://purl.obolibrary.org/obo/MONDO_0003549) (adenosquamous bile duct carcinoma), [MONDO:0002577](http://purl.obolibrary.org/obo/MONDO_0002577) (bile duct rhabdomyosarcoma), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), [MONDO:0003303](http://purl.obolibrary.org/obo/MONDO_0003303) (neurofibroma of gallbladder), [MONDO:0006219](http://purl.obolibrary.org/obo/MONDO_0006219) (gallbladder small cell neuroendocrine carcinoma), [MONDO:0004117](http://purl.obolibrary.org/obo/MONDO_0004117) (ampulla of vater small cell carcinoma), [MONDO:0004315](http://purl.obolibrary.org/obo/MONDO_0004315) (cholangiolocellular carcinoma), [MONDO:0003345](http://purl.obolibrary.org/obo/MONDO_0003345) (hilar cholangiocarcinoma), [MONDO:0004115](http://purl.obolibrary.org/obo/MONDO_0004115) (gallbladder small cell carcinoma), [MONDO:0006217](http://purl.obolibrary.org/obo/MONDO_0006217) (gallbladder adenosquamous carcinoma), [MONDO:0003500](http://purl.obolibrary.org/obo/MONDO_0003500) (squamous cell bile duct carcinoma), [MONDO:0006216](http://purl.obolibrary.org/obo/MONDO_0006216) (gallbladder adenoma), [MONDO:0004039](http://purl.obolibrary.org/obo/MONDO_0004039) (papillary extrahepatic bile duct adenocarcinoma), [MONDO:0002576](http://purl.obolibrary.org/obo/MONDO_0002576) (embryonal extrahepatic bile duct rhabdomyosarcoma), [MONDO:0003420](http://purl.obolibrary.org/obo/MONDO_0003420) (bile duct cystadenoma), [MONDO:0006215](http://purl.obolibrary.org/obo/MONDO_0006215) (gallbladder adenocarcinoma), [MONDO:0001487](http://purl.obolibrary.org/obo/MONDO_0001487) (intrahepatic gall duct cancer), [MONDO:0003388](http://purl.obolibrary.org/obo/MONDO_0003388) (ampulla of vater clear cell adenocarcinoma), [MONDO:0003026](http://purl.obolibrary.org/obo/MONDO_0003026) (gallbladder angiosarcoma), [MONDO:0004474](http://purl.obolibrary.org/obo/MONDO_0004474) (gallbladder lymphoma), [MONDO:0004078](http://purl.obolibrary.org/obo/MONDO_0004078) (mucinous intrahepatic cholangiocarcinoma), [MONDO:0004353](http://purl.obolibrary.org/obo/MONDO_0004353) (extrahepatic biliary papillomatosis), [MONDO:0003220](http://purl.obolibrary.org/obo/MONDO_0003220) (gallbladder carcinoma), [MONDO:0003060](http://purl.obolibrary.org/obo/MONDO_0003060) (biliary tract cancer), [MONDO:0002868](http://purl.obolibrary.org/obo/MONDO_0002868) (bile duct cystadenocarcinoma), [MONDO:0006709](http://purl.obolibrary.org/obo/MONDO_0006709) (common bile duct neoplasm), [MONDO:0000921](http://purl.obolibrary.org/obo/MONDO_0000921) (ampulla of vater neoplasm), [MONDO:0021321](http://purl.obolibrary.org/obo/MONDO_0021321) (malignant tumor of extrahepatic bile duct), [MONDO:0002669](http://purl.obolibrary.org/obo/MONDO_0002669) (ampullary signet ring cell adenocarcinoma), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0002665](http://purl.obolibrary.org/obo/MONDO_0002665) (extrahepatic bile duct adenocarcinoma), [MONDO:0000488](http://purl.obolibrary.org/obo/MONDO_0000488) (periampullary adenoma), [MONDO:0007318](http://purl.obolibrary.org/obo/MONDO_0007318) (Alagille syndrome), [MONDO:0006108](http://purl.obolibrary.org/obo/MONDO_0006108) (bile duct adenoma), [MONDO:0002667](http://purl.obolibrary.org/obo/MONDO_0002667) (gallbladder signet ring cell adenocarcinoma), [MONDO:0002862](http://purl.obolibrary.org/obo/MONDO_0002862) (bile duct sarcoma), [MONDO:0005411](http://purl.obolibrary.org/obo/MONDO_0005411) (gallbladder cancer), [MONDO:0002664](http://purl.obolibrary.org/obo/MONDO_0002664) (bile duct signet ring cell carcinoma), [MONDO:0003553](http://purl.obolibrary.org/obo/MONDO_0003553) (ampulla of vater adenosquamous carcinoma), [MONDO:0005496](http://purl.obolibrary.org/obo/MONDO_0005496) (bile duct carcinoma), [MONDO:0004484](http://purl.obolibrary.org/obo/MONDO_0004484) (gallbladder melanoma), [MONDO:0006220](http://purl.obolibrary.org/obo/MONDO_0006220) (gallbladder squamous cell carcinoma), [MONDO:0003193](http://purl.obolibrary.org/obo/MONDO_0003193) (bile duct adenocarcinoma), [MONDO:0004081](http://purl.obolibrary.org/obo/MONDO_0004081) (bile duct clear cell adenocarcinoma), 

**Mapped go classes:** [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0007154](http://purl.obolibrary.org/obo/GO_0007154) (cell communication), [GO:0005112](http://purl.obolibrary.org/obo/GO_0005112) (Notch binding), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0001944](http://purl.obolibrary.org/obo/GO_0001944) (vasculature development), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001946](http://purl.obolibrary.org/obo/GO_0001946) (lymphangiogenesis), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0060872](http://purl.obolibrary.org/obo/GO_0060872) (semicircular canal development), [GO:0060351](http://purl.obolibrary.org/obo/GO_0060351) (cartilage development involved in endochondral bone morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0042246](http://purl.obolibrary.org/obo/GO_0042246) (tissue regeneration), [GO:0060117](http://purl.obolibrary.org/obo/GO_0060117) (auditory receptor cell development), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), 

**Class expressions from DL-Learner:**

- [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration) 53.85%
- [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development) 53.85%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 53.85%
- [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development) 53.85%
- [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development) 53.85%
- [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development) 53.85%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 52.35%
- Thing 52.31%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 48.98%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) 39.20%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) and ([GO:0005603](http://purl.obolibrary.org/obo/GO_0005603) (obsolete complement component C2 complex) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.20%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) and ([GO:0005580](http://purl.obolibrary.org/obo/GO_0005580) (obsolete membrane attack complex protein alphaM chain) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.20%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.20%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) and ([GO:0005574](http://purl.obolibrary.org/obo/GO_0005574) (obsolete DNA) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.20%
- [GO:0031100](http://purl.obolibrary.org/obo/GO_0031100) (animal organ regeneration) and ([GO:0005573](http://purl.obolibrary.org/obo/GO_0005573) (obsolete telomerase RNA) or [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process)) 39.20%


